Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $1.91 Million - $3.18 Million
-57,742 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$50.07 - $66.05 $350,490 - $462,350
-7,000 Reduced 10.81%
57,742 $2.89 Million
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $3.67 Million - $5.21 Million
64,742 New
64,742 $4.08 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $493M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Quinn Opportunity Partners LLC Portfolio

Follow Quinn Opportunity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.